HDAC9 and major depressive disorder: Although most HDAC inhibitors have been developed for the hematological malignancies, an increasing number of HDAC inhibitors are investigated for the treatment of central nervous system (CNS) diseases such as brain cancers, Alzheimer’s disease, depression, and drug addiction6,21.